38th EORTC-NCI-AACR Symposium
Dr Robert BaxterNetworkingRegistration includes a networking reception, poster/exhibition area and three days…View detail
Registration includes a networking reception, poster/exhibition area and three days of in-person international oncology research exchange.
Research ValueThe meeting is centred on preclinical, phase I and translational…View detail
The meeting is centred on preclinical, phase I and translational oncology studies, with regular and late-breaking abstract routes plus public release of accepted abstract content.
Trainee RelevanceStudent and resident registration is explicitly available, and selected abstracts…View detail
Student and resident registration is explicitly available, and selected abstracts can enter the scientific programme, making this useful for oncology trainees with drug-development or translational research work.
ProgrammeSchedule and session highlights＋
SpeakersKeynotes and featured experts＋
AbstractsClosed · 8 Jul 2026＋
Costs & registrationTrainee tickets €390＋
| Category | Price |
|---|---|
| Early bird registration | €595 |
| Standard registration | €840 |
| Trainee / IMT | €390 |
| Medical student | €390 |
Dates & deadlines3 key dates＋
Venue & travelCCIB Barcelona · Barcelona＋
MedicMess tips4 practical tips＋
MedicMess Tips
- Early academic/institutional registration ended 24 June 2026; regular rates apply until 30 September 2026 and late rates until 4 November 2026.
- Late-breaking abstract submission is open 12-19 October 2026 and is not an extension of the regular abstract deadline.
- The meeting is face to face only; registration includes access to webcasts for three months after the symposium.
- All visible registration prices are in EUR and summary cost fields store EUR amounts without currency conversion.
Complete guideFull MedicMess editorial briefing＋
The 38th EORTC-NCI-AACR Symposium is a three-day in-person oncology research meeting in Barcelona for clinicians, scientists, translational researchers and industry teams working on molecular targets and cancer therapeutics. The programme is being built around drug development, target selection, emerging molecular biology and early-phase translational research, with a searchable programme and programme overview advertised by the organisers. Abstract submission ran from 13 April to 8 July 2026, with a late-breaking abstract window from 12 to 19 October 2026. The published topic list spans angiogenesis, ADCs, cellular therapies, artificial intelligence, biomarkers, cancer genomics, DNA repair, immuno-oncology, novel clinical trial design, paediatric oncology, vaccines and translational studies. Selected abstract titles are due to enter the programme after author notification, with most abstracts released on 4 November 2026 or on the day of presentation. Registration is tiered in euros: academic/institutional regular registration is 840 EUR, student/resident regular registration is 390 EUR, and early academic registration was 595 EUR. The event is face to face only and registration includes the scientific programme, opening ceremony, networking reception, exhibition/poster area, lunches, coffee breaks and three months of webcast access.
Get Oncology abstract deadlines — and every new conference — emailed to you every Saturday. Free.
No spam. Unsubscribe anytime.